glp 1 and 2 agonist Targeting GLP-1, GIP & GCG in Obesity Type Diabetes Research glp-1_analogs [TUSOM | Pharmwiki]
Description
68 demonstrated that exenatide combined with metformin resulted in an 86% ovulation rate, significantly higher than the 50% ovulation rate in the exenatide-only group and 29% in the metformin-only group
![glp 1 and 2 agonist Targeting GLP-1, GIP & GCG in Obesity Type Diabetes Research glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Other Benefits: Lower testosterone levels, improved menstrual cycles, better blood sugar control, and reduced cardiovascular risks
![glp 1 and 2 agonist Targeting GLP-1, GIP & GCG in Obesity Type Diabetes Research glp-1_analogs [TUSOM | Pharmwiki]](https://guides.secondnature.io/wp-content/uploads/2023/11/GLP-1hormone.png)
However, genetic variations in GLP-1R sensitivity, DPP-4 enzyme activity, and metabolic efficiency can influence individual response
![glp 1 and 2 agonist Targeting GLP-1, GIP & GCG in Obesity Type Diabetes Research glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00592-024-02300-6/MediaObjects/592_2024_2300_Fig1_HTML.png)
2024;73:767-P
![glp 1 and 2 agonist Targeting GLP-1, GIP & GCG in Obesity Type Diabetes Research glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/383495995/figure/fig1/AS:11431281459381455@1748120716657/Glucagon-like-peptide-1-receptor-agonist-GLP-1RA-mechanisms-of-action-in-type-2.png)
The results showed that cinchonine had a good binding affinity with GLP-1R (Total score=7.19
![glp 1 and 2 agonist Targeting GLP-1, GIP & GCG in Obesity Type Diabetes Research glp-1_analogs [TUSOM | Pharmwiki]](https://medrac.web.unc.edu/wp-content/uploads/sites/22579/2025/03/AD_4nXecYXk7BfwC6adHH808V596nosg2pYs4yDUs6TBM_JMmx7_pGkjqpOwyHWy2Rj2TdJt-SPUxEipYqiO5CftWX-CaAm_fXRTU6dpEuJkuUscaLenZ1xGLWDdf_XVsOIjaZt08BpA4A.png)
15 As a result, public companies are already seeing a growing number of questions from investors and media around GLP-1RAs and the impact they may have on their business
![glp 1 and 2 agonist Targeting GLP-1, GIP & GCG in Obesity Type Diabetes Research glp-1_analogs [TUSOM | Pharmwiki]](https://www.amjmed.com/cms/10.1016/j.amjmed.2025.01.021/asset/0677e414-18c2-4dd6-9f70-73bf9a12fc8e/main.assets/gr2_lrg.jpg)